These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 12378867
1. [Drug positioning of parenteral fluoroquinolones in management of infectious diseases. Discussion]. Kobayashi H, Aikawa N, Saito A, Shuden S, Minami S. Jpn J Antibiot; 2002 Aug; 55(4):345-60. PubMed ID: 12378867 [No Abstract] [Full Text] [Related]
2. Bacterial challenges and evolving antibacterial drug strategy. Watt B, Collee JG. Postgrad Med J; 1992 Jan; 68(795):6-21. PubMed ID: 1561196 [No Abstract] [Full Text] [Related]
4. Role of oral fluoroquinolones as an alternative to traditional parenteral therapy for patients with serious infections. Ball P. Clin Invest Med; 1989 Feb; 12(1):69-70. PubMed ID: 2920483 [No Abstract] [Full Text] [Related]
9. Activity of quinolones against Chlamydia pneumoniae. Hammerschlag MR. Drugs; 1999 Feb; 58 Suppl 2():78-81. PubMed ID: 10553711 [Abstract] [Full Text] [Related]
10. [Chinolone--the survey remembered]. Heinzl S. Med Monatsschr Pharm; 1998 Aug; 21(8):229. PubMed ID: 9729673 [No Abstract] [Full Text] [Related]
11. The quinolones and renal infection. Ronald A. Drugs; 1999 Aug; 58 Suppl 2():96-8. PubMed ID: 10553715 [Abstract] [Full Text] [Related]
12. [Fluoroquinolones in antimicrobial therapy and prophylaxis in surgery]. Vyhnánek F, Lochmann O. Rozhl Chir; 1995 Sep; 74(6):257-61. PubMed ID: 8658272 [Abstract] [Full Text] [Related]
13. [Fluoroquinolones and their importance in modern chemotherapy of infectious diseases]. Padeĭskaia EN. Antibiot Khimioter; 1989 Jul; 34(7):514-21. PubMed ID: 2818083 [Abstract] [Full Text] [Related]
14. [Enrofloxacin, a new drug for ornamental fish]. Reimlinger M, Hoffmann R, Pfeil-Putzien C, Scheinert P. Tierarztl Prax; 1990 Dec; 18(6):653-7. PubMed ID: 2080513 [Abstract] [Full Text] [Related]
15. Oral fluoroquinolone versus mono- or combination parenteral therapy in the management of bacterial infections: a critical appraisal. Guay DR. DICP; 1990 Jan; 24(1):11-8. PubMed ID: 2405585 [Abstract] [Full Text] [Related]
16. [The place of the new quinolones in the guidelines on the treatment of community-acquired pneumonia]. Dorca J. Arch Bronconeumol; 1999 May; 35 Suppl 3():77-80. PubMed ID: 10410230 [No Abstract] [Full Text] [Related]
17. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities. Siporin C. Annu Rev Microbiol; 1989 May; 43():601-27. PubMed ID: 2679364 [Abstract] [Full Text] [Related]
18. [The role of quinolones in the treatment of community acquired pneumonia]. Garau J. Med Clin (Barc); 1998 Feb; 110 Suppl 1():31-5. PubMed ID: 9717158 [No Abstract] [Full Text] [Related]
19. The role of the fluoroquinolones in primary care practice. Harding GK. Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484 [No Abstract] [Full Text] [Related]
20. The place of quinolones in bacterial infections. Neu HC. Adv Intern Med; 1991 Feb; 36():1-32. PubMed ID: 2024577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]